Gratacos, Jordi; Pontes, Caridad; Juanola, Xavier; Sanz, Jesús; Torres, Ferran; Avendano, Cristina; Vallano, Antoni; Calvo, Gonzalo; de-Miguel, Eugenio; Sanmarti, Raimon; Almirall, Miriam; Aparicio, María; Sellas, Agusti; Vives, Roser; Albinana, Nestor; Moreno, Mireia; Clavaguera, Teresa; Torre-Alonso, Juan-Carlos; Veroz, Raúl; Rodríguez-Lozano, Carlos; Linares, Luis-Francisco; Urruticoechea, Ana; Collantes, Eduardo; Morla, Rosa-María; Reina, Delia; Cuende, Eduardo; Zarco, Pedro; Cruz-Fernández-Espartero, María; García-Vicuna, Rosario; Alberto-Montilla, Carlos; Villalba, Alejandro; Pascual, Dora; Campos, Cristina; Juan, Antonio; Ariza, Rafael; Díaz-Miguel, Consuelo; Maqueda, Manuel; Pilar-Fernández-Dapica, María; Fernández-Prada, Manuel; Batlle, Enrique; González-Fernández, Carlos; Queiro, Rubén
(BMC, 2019-01-08)
OBJECTIVE: The objective was to determine if dose reduction is non-inferior to full-dose TNFi to maintain low disease activity (LDA) in patients already in remission with TNFi, in axial spondyloarthritis. METHODS: Randomized, ...